Pulse2
Published November 9, 2026
Delix Therapeutics: $100 Million Series C Funding To Advance Zalsupindole Into Phase II Trials
psychedelics . This distinction could be important for developing treatments suitable for outpatient or at-home administration, although the drug's.
Surfaced by this Google Alert
- Psychedelics